Limited Submission Opportunity: St. Baldrick’s Foundation Fellowship Award 2026

URL: https://www.stbaldricks.org/file/sbf-fellowship-grant-guidelines.pdf

OBJECTIVES

The St. Baldrick’s Foundation is a volunteer and donor powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives.

In addition to research to understand the biology of childhood cancers and discover

leads to more effective treatments, topics of interest include, but are not limited to:

  • Adolescents & young adults
  • Survivorship, outcomes, and quality of life
  • Supportive care
  • Epidemiology and pediatric cancer predispositions
  • Precision medicine
  • Alternative & complementary therapies

FUNDING INFORMATION

Up to $97,500 per year for a 2-year Fellowship ($195,000 total) with a potential additional year of funding based upon the demonstration of need and significant accomplishment. The award covers salary and benefits only.

ELIGIBILITY

Applicants must:

  • Hold an M.D. or D.O. degree by the date the grant becomes effective.
  • Be employed by an academic or non-profit research institution or laboratory.
  • Be in their 2nd or 3rd year of pediatric oncology fellowship by July 1, 2026. Exceptions are allowed for a research residency format (2 years of residency 4 years of fellowship).
    • If the applicant fits a research residency format exception, please indicate this in the InfoReady Review application so that it can be included in the LOI.
  • Not hold an appointment of assistant professor or above.
  • Have a fellowship mentor who provides supervision, facilities, and research support at an American Board of Pediatrics approved fellowship program in Pediatric Hematology/Oncology. A co-mentor is allowed.

INTERNAL SELECTION PROCESS

BU may submit 1 Fellowship application. However, a second application may be forwarded if the project focuses on one of the following areas:

  • Brain tumors – all types, including rare forms, especially atypical teratoid/rhabdoid tumor (AT/RT), diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG), and glioblastoma (GBM)
  • Burkitt lymphoma – all types, especially sporadic
  • Rhabdoid tumors – Extrarenal

Interested candidates should submit the following materials via InfoReady Review by: 5/30/2025

  • Short Questions outlined in InfoReady Review
  • 2-page Project Summary describing its aims, rationale, and methods
  • Up-to-date biosketch for the PI and their Mentor

Foundation Relations will work with the nominee(s) to develop and submit the LOI and applicant materials by 7/8/2025.

DEADLINES

Internal Materials Due: Friday, May 30, 2025 by 11:59 pm ET

Anticipated Notification Date: Monday, June 9, 2025

Letter of Intent Due: Tuesday, July 8, 2025 by 5:00 pm ET

View all posts

Information For...